Beatrice Costea

Beatrice Costea is a multilingual medical professional with over 20 years of experience in the pharmaceutical industry, specializing in pathology and various roles within Medical Affairs, Market Access, and Evidence/Clinical Research. Currently serving as the Medical TA Lead Haemato-Oncology at AstraZeneca, Beatrice has demonstrated expertise in engaging stakeholders and developing access strategies in the EU healthcare environment. Previously, they held positions such as Investigator Initiated Studies Coordinator and Payer Evidence Manager, contributing to successful market access and evidence generation across multiple therapeutic areas. Beatrice possesses a strong educational background, holding an MD and an EMBA, along with advanced training in health technology assessment and pharmacoeconomics.